Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with <sup>68</sup>Ga(III) and <sup>45</sup>Ti(IV)
Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup>, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2-</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup>, and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> form readily at room temperature within 15 min with a molar activity of 24-29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2-</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> complex is observed when compared with that of [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> is excreted >98% intact, while [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup> isotopes.
Authors
- Angus J. Koller (ORCID: https://orcid.org/0000-0002-3000-8201)
- Martin Dierolf (ORCID: https://orcid.org/0000-0001-5150-2949)
- Molly C. DeLuca
- Valérie C. Pierre (ORCID: https://orcid.org/0000-0002-0907-8395)
- Eduardo Alucio-Sarduy
- Axia Marlin (ORCID: https://orcid.org/0009-0004-1044-8885)
- Eszter Boros (ORCID: https://orcid.org/0000-0002-4186-6586)
- Dariusz Śmiłowicz
- Phuong Tran (ORCID: https://orcid.org/0009-0001-6844-6661)
- Jonathan W. Engle (ORCID: https://orcid.org/0000-0002-3399-7228)
- Owen M. Glaser
- M. Andrey Joaqui Joaqui
- Mallory J. Gork
Institutions
- University of Wisconsin–Madison (US)
- University of Utah (US)
- Stony Brook University (US)
Publication Details
- Journal
- Bioconjugate Chemistry
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1021/acs.bioconjchem.5c00099
- Citations
- 1
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- U.S. Department of Energy
- National Institute of Biomedical Imaging and Bioengineering
- Division of Chemistry